A new publication regarding insulin degludec's related once-weekly compound, insulin icodec, appeared on July 28, 2026. The article, titled "Pharmacokinetics, Clinical Efficacy, and Safety of Once-Weekly Insulin Icodec: A Structured Narrative Review (2022-2026)," was published in the journal Cureus.
The publication is described as a structured narrative review, compiling literature spanning 2022 through 2026 on the pharmacokinetics, clinical efficacy, and safety of insulin icodec. No specific findings, results, or conclusions from the review were provided in the available event data.
This entry reflects only the fact that the review was published and its stated scope, as recorded in the source listing. It does not include details of the review's content, methodology, or any conclusions reached by its authors.
Readers interested in insulin degludec more broadly, including its approved regulatory status, can consult the compound overview for additional context.